Welcome to InfiCure Bio
InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.
Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.
Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.
News
Visit Innosers NIF poster at Global NASH!
Please take the chance to talk to InnoSer about InfiCure Bio ABs unique NIF mouse model at the 6th NASH Congress! The NIF model spontaneously develops chronic inflammation and fibrosis, which is nicely presented in [...]
Strong start to 2023 with a US deal!
InfiCure Bio has started 2023 by signing an agreement with a new client in the US. Read the whole pressrelease here
Christmas lunch in winter wonderland!
InfiCure Bio enjoyed a traditional Swedish Christmas lunch at beautiful Brännlands Wärdshus. It is hard to find a more Christmasy atmosphere- and the recent snow and cold weather added an extra touch. We wish you [...]
Pressrelease: InnoSer and Inficure Bio enter partnership
InnoSer and Inficure Bio enter partnership to increase accessibility of translational liver inflammation & fibrosis mouse model Read the entire pressrelease here!